1.0Cilcarehttps://www.cilcare.com/jprich600338<blockquote class="wp-embedded-content" data-secret="XXBHTG5pFa"><a href="https://www.cilcare.com/jp/our-missions-external-innovation/modalities/">治療法</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cilcare.com/jp/our-missions-external-innovation/modalities/embed/#?secret=XXBHTG5pFa" width="600" height="338" title="“therapeutic modalities” — Cilcare" data-secret="XXBHTG5pFa" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cilcare.com/wp-includes/js/wp-embed.min.js </script>therapeutic modalities small molecules, peptides, antibodies, large molecules Cilcare offers a comprehensive solution for drug candidate development. We specialize in robust evaluation, supporting candidates from initial screening through IND-enabling studies. Our expertise and resources ensure your compounds are rigorously assessed and optimized for future clinical trials. gene & cell therapies About 60% of sensorineural hearing loss can be attributed to genetic factors. So far, we know that over 400 genes are linked to some form of hearing loss. Cell and gene therapy programs are addressing the need for cell specificity for the treatment of both genetic and acquired hearing loss. One approach uses a traditional cell-based method of directly replacing […]